Titre :
|
Multiresistant non-fermentative Gram-negative bacteria in cystic fibrosis patients : the results of an Italian multicenter study. (1999)
|
Auteurs :
|
G. TACCETTI ;
S. CAMPANA ;
L. MARIANELLI ;
Cystic Fibrosis Center. Meyer Hospital. University of Florence. ITA ;
Italian Group for Cystic Fibrosis Microbiology. ITA
|
Type de document :
|
Article
|
Dans :
|
European journal of epidemiology (vol. 15, n° 1, 1999)
|
Pagination :
|
85-88
|
Langues:
|
Anglais
|
Mots-clés :
|
Mucoviscidose
;
Bactériose
;
Infection
;
Médicament antibiotique
;
Epidémiologie
;
Thérapeutique médicamenteuse
;
Thérapeutique
;
Microbiologie
;
Homme
;
Italie
;
Europe
;
Appareil respiratoire [pathologie]
;
Appareil digestif [pathologie]
;
Pancréas [pathologie]
;
Maladie héréditaire
;
Métabolisme [pathologie]
|
Résumé :
|
[BDSP. Notice produite par INIST yDR0xdqA. Diffusion soumise à autorisation]. We carried out an epidemiological study on 2717 patients seen on a regular basis at Italian Cystic Fibrosis Centers with the aim of defining the prevalence of multiresistant Gram-negative strains in Italy. We found 272 multiresistant strains out of 1560 Gram-negative strains isolated in 1012 Italian cystic fibrosis patients. From our results in Italian cystic fibrosis patients we may conclude : (1) the beta-lactam antibiotics are moderately active ; ceftazidime is the most efficacious even if 59.9% of multiresistant strains are not sensitive to this drug ; (2) the aminoglycosides are poorly efficacious ; 93% of multiresistant strains are resistant in vitro to tobramycin ; and (3) the quinolones, notwithstanding their relatively recent introduction into clinical practice, have very poor activity against multiresistant strains, 89.7% of which are not sensitive.
|